Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative effects of estradiol/nomegestrol acetate vs estetrol/drospirenone in women with PCOS
TCTR20260208003Phase 4Not yet recruiting
- Sponsor
- Mookrawee Darachai
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nomegestrol acetate + estradiol, estetrol + drospirenone in polycystic ovary syndrome (PCOS), sponsored by Mookrawee Darachai. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nomegestrol acetate + estradiolestetrol + drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on TCTR20260208003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260208003.